Capecitabine

Product Name: Capecitabine

Other Names: Xeloda, Capiibine, Capecitibine, Ro 09-1978

Product Introduction: Capecitabine is an oral fluoropyrimidine carbamate designed as a prodrug of 5-fluorouracil (5-FU), selectively activated in tumor cells to inhibit DNA synthesis. Its tumor-specific conversion enhances efficacy and reduces systemic toxicity, making it a cornerstone for treating colorectal, breast, and gastric cancers.

CAS Number: 154361-50-9

Molecular Formula: C15H22FN3O6

Specification: Available in 150 mg and 500 mg tablets, with purity ≥98% for pharmaceutical use.

Appearance: White crystalline powder

Ingredient: Capecitabine as the active pharmaceutical ingredient, with excipients like microcrystalline cellulose and magnesium stearate in tablet formulations.

Functions: Inhibits tumor growth by converting to 5-FU, which disrupts DNA and RNA synthesis. Used as a single agent or in combination for metastatic colorectal cancer, adjuvant treatment of stage III colon cancer, and metastatic breast cancer resistant to other therapies.